HCCI allows researchers and policymakers unprecedented access to health plan and government payer data and research on health care costs and utilization.
From 2018-2022, more people with ESI used mental health services, primarily therapy.
Read more about mental health service use trends here: https://t.co/VkY8gxVkwI
DYK >40% of mental health visits occurred via telehealth from 2020-2022?
Read more about the role telehealth plays in mental health care here: https://t.co/FbBdR1bb2L
The 2024 iFHP & HCCI International Health Cost Comparison Report found prices for 25 health services in 9 countries, plus prescription drug costs in 5 countries, using 2022 private insurance data. #HealthCareCost#GlobalHealth#Insurance
https://t.co/CJnPq43wd6
Carve Carefully this Holiday Season! We see a rise in sharp object encounters on Turkey Day. If you are participating in family dinner this turkey day, carve carefully! 🦃
🚨NEW PAPER🚨
Using #HCCIdata, we examine how commercial inpatient price growth differs by hospital type over the last decade. System-affiliated and non-profit hospital prices grew fastest compared to counterparts.
@Health_Affairs Scholar
https://t.co/rUyUV7s3Cs
Since the first biosimilar launch, the uptake of biosimilars in the ESI population has been steadily increasing across most drug classes. Early signs point to savings in total spending among administered drug classes with biosimilar competitors.
More here: https://t.co/ZklV85um3A
Diagnosed chronic kidney disease among the Medicare population was 18% in 2022. The expected prevalence of CKD nationally is 34% which could indicate underdiagnosis of CKD in claims data.
Dive deeper with the HCCI & NKF Chronic Kidney Disease Dashboard: https://t.co/0ofXNWCWm7
People diagnosed with obesity who get insurance at work were prescribed anti-obesity medications at over 4x the rate of people with Medicaid.
Learn more about the differences in utilization of obesity treatments among the Medicaid and ESI populations: https://t.co/zJ2YiUNneg
We collaborated with @nkf and @TheDataFace to create a multi-payer dashboard to examine the current state of chronic kidney disease related care in the US.
Explore relevant metrics at a national, state, or CBSA level here:
https://t.co/veOcDdEb6v
Today is World Menopause Day 🌎🗒️🩺📊!
Our new brief shows that just under 15% of women aged 45-64 had a menopause diagnosis code on a health care encounter during 2022. #HCCIData
https://t.co/wDFf1jaJvJ
Register now for NAHDO's 39th Annual Conference (Fully Virtual), November 12-14! We are excited to announce a full agenda of fabulous and engaging presenters and panels. Please visit the conference website (https://t.co/suujhJbQ4B) to see the agenda and to register.